Biogen saw the highest growth of 1.42% in patent filings in May and 1.49% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.6% and grants by 0.88%. GlobalData’s DataBook provides a comprehensive analysis of Biogen‘s patent filings and grants. Buy the databook here.
Biogen has been focused on protecting inventions in United States(US) with 17 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 28% filings and 22% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where Biogen is filings its patents. Among the top granted patent authorities, Biogen has 22% of its grants in United States(US), 17% in Israel(IL) and 9% in Australia(AU).
Roche could be the strongest competitor for Biogen
In terms of grant share, Biogen stands in sixth position among its competitors. Biogen and Roche secured the top positions according to recent patent publication data.
Patents related to rare diseases and artificial intelligence lead Biogen's portfolio
Biogen has the highest number of patents in rare diseases followed by, artificial intelligence and climate change. For rare diseases, nearly 70% of patents were filed and 92% of patents were granted in Q2 2024.
Alzheimer's disease related patents lead Biogen portfolio followed by epilepsy, and cardiovascular disease
Biogen has highest number of patents in alzheimer's disease followed by epilepsy, cardiovascular disease, multiple sclerosis, and pain. For alzheimer's disease, nearly 4% of patents were filed and 3% of patents were granted in Q2 2024.
For comprehensive analysis of Biogen's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.